Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SpePharm AG

Division of Norgine BV
www.spepharm.com

Latest From SpePharm AG

Deals Shaping The Medical Industry, April 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced March 2015.

BioPharmaceutical Medical Device

PledPharma Readies PledOx For Phase III FDA Talks And Partnering

PledPharma unveiled potentially transforming Phase IIb top-line results for its new medicine PledOx, which aims to reduce severe side effects from chemotherapy. The Swedish small cap firm now will engage with regulators to map out its Phase III program – and woo potential commercial partners for the needed financing.

BioPharmaceutical Sweden

Deals Shaping The Medical Industry, May 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced March through April 2014

BioPharmaceutical Medical Device

Deals Shaping the Medical Industry (10/2011)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Nutraceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Dental & Oral Products
  • Gastrointestinal
  • Infectious & Viral Diseases
  • Alias(es)
  • SpePharm Holding BV
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Benelux
          • Netherlands
  • Parent & Subsidiaries
  • Norgine BV
  • Senior Management
  • Jean-François Labbé, CEO
    Neil L Brown, PhD, CBO
  • Contact Info
  • SpePharm AG
    Phone: (31) 88 0074501
    Kingsfordweg 151
    GR Amsterdam, 1043
    Netherlands
Advertisement
Advertisement
UsernamePublicRestriction

Register